BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations

NCT03608371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Motor Disorder

Interventions

DRUG: BTRX-246040
DRUG: Placebo

Sponsor

BlackThorn Therapeutics, Inc.